Keywords : animal feed additive, Agriculture, veterinarian, veterinary service
REPORT SCOPE INTRODUCTION STUDY GOALS AND OBJECTIVES This BCC Research report, Global Markets for Animal Therapeutics and Diagnostics, provides an overview of products included in this market and detailed market analyses and competitive environments. The study includes information about significant products, players, issues and trends, and other information affecting the animal therapeutic and diagnostic...
More »
Search ReportLinker
The Largest Collection of Market Research Reports
» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides
From +200,000 authoritative sources
REPORT SCOPE
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This BCC Research report, Global Markets for Animal Therapeutics and Diagnostics, provides an overview of products included in this market and detailed market analyses and competitive environments. The study includes information about significant products, players, issues and trends, and other information affecting the animal therapeutic and diagnostic market.
REASONS FOR DOING THE STUDY
The animal health industry is responsible for maintaining the health and productivity of the over 3.3 billion livestock and 16 billion poultry worldwide and ensuring the wholesomeness and abundance of the food they produce. In addition, the industry must also cater to the health and well being of companion animals. Despite this, the human healthcare market is 35 times larger than the combined market for all nonhuman species. The reality is that the global animal health market is very complex, operating under stringent and increasingly strict regulations similar to those for human health, yet the market opportunities are considerably smaller. In an increasingly risky environment for new product development, the difference between success and failure in the future usually lies in successfully identifying the next growth segment, developing the right product candidates and being the first to market. Despite all these risks, the industry continues to grow.
In contrast to human blockbuster-oriented pharmaceuticals, animal health is dominated by large numbers of products with small revenues. Although there are hundreds of products involved in this market, only about 30 products have sales exceeding $100 million per year. However, the industry continues to forge on. The fastest growing therapeutic categories are in the area of companion animals, specifically in the arthritis and pain segments of the market.
A challenging aspect of the market is within the animal food industry as consumers continue to express concern about the conditions under which their daily food is produced. Consumers are becoming more health conscious and demanding healthy and balanced diets. By implementing a feeding plan that provides vitamins and supplements, consumers enjoy additional nutritional benefits. Additionally, healthy feeding results in minimized impact on the environment.
INTENDED AUDIENCE
The information within this report is directed at the business and industry professional and is specifically designed to aid in the explanation, direction and future of animal health markets. The report focuses on providing the reader with an understanding of trends in the industry, market segments, market forecasts, leading players, market drivers and inhibitors.
SCOPE OF REPORT
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutic and diagnostic market. The geographical scope of this study is worldwide, with special interest for markets, trends and statistics by key geographical regions such as the United States, European countries and Brazil, Japan and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives and diagnostics. For the purpose of this study, diagnostics includes products that are used at the point of care and are considered rapid tests or kits. Each market segment provides detailed information based on product categories, use of products, forecasts and competitive analyses.
INFORMATION SOURCES
The information for this BCC report was obtained through primary and secondary data-collection methods. Primary methods included interviews with approximately 40 key executives, product managers and clinical specialists involved in the animal health industry. Secondary methods included published literature in the area of animal science and veterinary services, investment reports, company literature, and various animal health journals.
All market data pertains to the global market at the manufacturers’ level. Data are expressed in current U.S. dollars. The base year of the report is 2011, with historical data provided for 2008 through 2010, and forecast data provided for 2012 and 2016. Historical, base year and forecast data are provided for each market segment of the report. Competitor market share estimates are provided for each market segment for the 2011 base year.
Although this study provides information on a variety of products used to treat animals, it does not include a comprehensive list of all products available.
ANALYST CREDENTIALS
Melissa Elder is an experienced healthcare market analyst specializing in prescription and over-the-counter pharmaceuticals, medical devices, and emerging healthcare technologies. Ms. Elder has nearly 20 years of experience in the healthcare industry, specializing in market research for the past 14 years. This experience has given her substantial insight into pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare markets.
Global Agriculture Industry
TABLE OF CONTENTS
CHAPTER ONE: INTRODUCTION 1
STUDY GOALS AND OBJECTIVES 1
REASONS FOR DOING THE STUDY 1
INTENDED AUDIENCE 2
SCOPE OF REPORT 2
INFORMATION SOURCES 2
RELATED BCC RESEARCH REPORTS 3
ANALYST CREDENTIALS 3
BCC ON-LINE SERVICES 3
DISCLAIMER 3
CHAPTER TWO: SUMMARY 4
SUMMARY 4
SUMMARY TABLE TOTAL ANIMAL THERAPEUTICS AND
DIAGNOSTICS MARKET BY MAJOR SEGMENT, THROUGH 2016 ($
MILLIONS) 5
SUMMARY FIGURE TOTAL ANIMAL THERAPEUTICS AND
DIAGNOSTICS MARKET BY MAJOR SEGMENT, 2008-2016 ($
MILLIONS) 5
LEADING PRODUCTS AND MANUFACTURERS 6
CHAPTER THREE: INDUSTRY OVERVIEW 7
ANIMAL ANATOMY AND PHYSIOLOGY 7
ANIMAL ANATOMY AND PHYSIOLOGY (CONTINUED) 8
REPRODUCTIVE SYSTEM 9
TABLE 1 GESTATION PERIODS OF SELECT COMMON SPECIES 10
AVIAN ANATOMY 10
Avian Anatomy (Continued) 11
Avian Anatomy (Continued) 12
TABLE 2 LIFESPAN OF COMMON PET AVIAN SPECIES 13
ANIMAL POPULATIONS IN THE UNITED STATES 13
COMPANION ANIMALS 13
TABLE 3 U S HOUSEHOLD STATISTICS FOR COMPANION
ANIMALS, 2011 (THOUSANDS) 14
TABLE 4 U S ESTIMATED POPULATIONS OF COMPANION
ANIMALS, 2011 (THOUSANDS) 14
FOOD PRODUCTION ANIMALS 14
TABLE 5 U S REPORTED POPULATION OF FOOD PRODUCTION
ANIMALS, 2005 AND 2010* (MILLIONS) 15
ANIMAL POPULATIONS BY COUNTRY 15
DOGS 15
TABLE 6 DOG (CANINE) POPULATION BY COUNTRY, 2010
(THOUSANDS) 16
FIGURE 1 DOG (CANINE) POPULATION—TOP 10 COUNTRIES, 2010
(THOUSANDS) 17
CATS 17
TABLE 7 CAT (FELINE) POPULATION BY COUNTRY (THOUSANDS) 18
FIGURE 2 CAT (FELINE) POPULATION—TOP 10 COUNTRIES, 2010
(THOUSANDS) 19
HORSES 19
TABLE 8 HORSE (EQUINE) POPULATION BY COUNTRY
(THOUSANDS) 20
TABLE 8 (CONTINUED) 21
FIGURE 3 HORSE (EQUINE) POPULATION—TOP 10 COUNTRIES,
2010 (THOUSANDS) 21
FIGURE 3 (CONTINUED) 22
CATTLE 22
TABLE 9 CATTLE (BOVINE) POPULATION BY COUNTRY
(THOUSANDS) 22
TABLE 9 (CONTINUED) 23
FIGURE 4 CATTLE (BOVINE) POPULATION—TOP 10 COUNTRIES,
2010 (THOUSANDS) 24
SWINE 24
TABLE 10 PIG/HOG (SWINE) POPULATION BY COUNTRY
(THOUSANDS) 25
FIGURE 5 PIG/HOG (SWINE) POPULATION—TOP 10 COUNTRIES,
2010 (THOUSANDS) 26
SHEEP/LAMB 26
TABLE 11 SHEEP/LAMB POPULATION BY COUNTRY
(THOUSANDS) 27
FIGURE 6 SHEEP/LAMB POPULATION—TOP 10 COUNTRIES, 2010
(THOUSANDS) 28
GOATS 28
TABLE 12 GOAT POPULATION BY COUNTRY (THOUSANDS) 29
FIGURE 7 GOAT POPULATION—TOP 10 COUNTRIES, 2010
(THOUSANDS) 30
TABLE 13 COUNTRIES WITH THE HIGHEST REPORTED ANIMAL
POPULATIONS (MILLIONS) 31
COMPANION ANIMAL DISEASES 32
INFECTIOUS DISEASES 32
Viruses 32
Adenovirus 32
Avian Influenza 33
Coronavirus 33
Distemper 34
Eastern Equine Encephalitis 34
Equine Viral Arteritis 35
Feline Calicivirus and Feline Herpes Virus 35
Feline Immunosuppressive Virus 35
Feline Infectious Peritonitis Virus 36
Feline Leukemia Virus 36
Infectious Hepatitis 37
Internal Papillomatosis of Parrots 37
Newcastle Disease 37
Pacheco’s Disease 38
Parainfluenza Virus 39
Paramyxoviruses 39
Parvovirus 40
Polyomavirus 40
Poxviruses 40
Psittacine Beak and Feather Disease 41
Rabies 41
Reovirus 42
West Nile Virus 42
Bacteria 43
Black Tongue 43
Bordetella 43
Brucellosis 43
Campylobacteriosis 44
Chlamydia 44
Leptospirosis 45
Lyme Disease 45
Q Fever 46
Respiratory Mycoplasmosis 46
Spirochaetaceae 47
Tetanus 47
Allergy and Inflammatory Diseases 47
Allergies 47
Arthritis 48
Asthma 48
Dermatitis 49
Eosinophilic Granuloma Complex 49
Gout 49
Inflammatory Bowel Disease 50
Metabolic Diseases 51
Cushing’s Syndrome 51
Diabetes Mellitus 51
Thyroid Disease 52
Pancreatitis 53
Metabolic Bone Disease in Birds 53
Parasitic Diseases 54
Ear Mites 54
Fleas 54
Fleas (Continued) 55
Heartworm 56
Hemobartonellosis 57
Feline Scabies 57
Lice 57
Sarcoptic Mange 58
Worms 58
Urinary Diseases 59
Glomerulonephritis 59
Feline Lower Urinary Tract Disease 59
Other Diseases 60
Equine Protozoal Myelitis 60
Leptospirosis and Equine Recurrent Uveitis 61
Neoplastic Disease 61
Neoplastic … (Continued) 62
Heart Disease 63
FOOD ANIMAL DISEASES 63
INFECTIOUS DISEASES 63
Viruses and Prions 63
Avian Pneumovirus 64
Bovine Spongiform Encephalopathy 64
Bovine Viral Diarrhea 65
Classical Swine Fever 66
Foot and Mouth Disease 67
Furunculosis 67
Infectious Pancreatic Necrosis 67
Marek’s Disease 68
Pathogenic Avian Influenza 68
Q Fever 68
Vesicular Stomatitis 69
Bacteria 69
Anthrax 69
Blackleg 70
Conjunctivitis 70
Tetanus 70
OTHER DISEASES OF FOOD ANIMALS 71
Heartwater 71
Pneumonia 71
Texas Cattle Fever 72
ZOONOTIC DISEASES 72
ZOONOTIC DISEASES (CONTINUED) 73
ZOONOTIC DISEASES (CONTINUED) 74
TABLE 14 COMMON EXAMPLES OF ZOONOTIC DISEASES 75
CHAPTER FOUR: ISSUES AFFECTING THE MARKET 76
ANTIBIOTIC USE AND RESISTANCE IN FOOD ANIMALS 76
THERAPEUTIC USE 76
TABLE 15 CURRENT LIST OF APPROVED
ANTIBIOTICS/ANTIMICROBIALS USED IN FOOD-PRODUCING
ANIMALS IN THE UNITED STATES 77
TABLE 15 (CONTINUED) 78
Resistance 78
TABLE 16 ANTIMICROBIAL DRUG USE AND SALES IN FOODPRODUCING
ANIMALS, 2010 79
TABLE 16 (CONTINUED) 80
Human Side-Effects 80
Microbial Ecology 81
Agriculture and Food Research Initiative 81
Levels of Contaminated Meats in the U S 82
PROBIOTICS 82
LEGAL AND REGULATORY ISSUES 82
MINIMALLY AND HIGHLY REGULATED PRODUCTS 82
ANIMAL DRUG USER FEE ACT OF 2003 83
ANIMAL DRUG USER FEE AMENDMENTS OF 2008 (ADUFA
II) 83
ADVANCES IN DRUG DELIVERY 83
TRANSDERMAL (SPRAY-ON) DRUGS 83
SUBLINGUAL (UNDER THE TONGUE) DRUGS 84
BIOTECHNOLOGY IN ANIMAL HEALTH 84
ANIMAL CLONING 85
TRENDS IN COMPANION PET OWNERSHIP 85
TRENDS IN COMPANION … (CONTINUED) 86
ANIMAL HEALTH INSURANCE 87
TABLE 17 APPA NATIONAL PET OWNERS SURVEY, 2011-2012 BASIC
ANNUAL EXPENSES FOR DOGS AND CATS ($) 88
TABLE 18 DOG INSURANCE PLAN COMPARISONS, UNITED
STATES ($) 88
TABLE 18 (CONTINUED) 89
TABLE 19 CAT INSURANCE PLAN COMPARISONS, UNITED STATES
($) 89
ANIMAL OBESITY 90
CAUSES 90
WEIGHT REDUCTION 91
DEMAND IN THE VETERINARY SERVICE INDUSTRY 92
TABLE 20 ESTIMATED NUMBER OF VETERINARIAN PRACTICES IN
THE UNITED STATES BY TYPE OF PRACTICE, 2011 (NUMBER/%) 93
TABLE 21 ESTIMATED NUMBER OF VETERINARIAN’S IN THE
UNITED STATES BY YEAR, 2007–2011 93
FIGURE 8 ESTIMATED NUMBER OF VETERINARIAN’S IN THE
UNITED STATES BY YEAR, 2007-2011 94
ADVANCED MEDICAL PROCEDURES 94
ADVANCED MEDICAL PROCEDURES (CONTINUED) 95
ADVANCED MEDICAL PROCEDURES (CONTINUED) 95
LIFE CYCLE APPROACH 96
INTERNATIONAL ISSUES AND TRENDS 97
TABLE 22 ESTIMATED POPULATIONS OF COMPANION ANIMALS
IN JAPAN AND AUSTRALIA, 2010 (MILLIONS) 98
TABLE 23 ESTIMATED POPULATIONS OF FARM ANIMALS IN
ARGENTINA, BRAZIL AND INDIA, 2010 (MILLIONS) 99
CHAPTER FIVE: ANIMAL VACCINES 100
OVERVIEW 100
PRODUCT DESCRIPTION 100
ACTIVE IMMUNITY 100
PASSIVE IMMUNITY 101
OTHER TYPES 101
TARGET SPECIES AND PROVIDERS 102
TABLE 24 VACCINES BY TARGET SPECIES AND PROVIDERS 102
TABLE 24 (CONTINUED) 103
TABLE 24 (CONTINUED) 104
TABLE 24 (CONTINUED) 105
TABLE 24 (CONTINUED) 106
COMPANION ANIMAL VACCINES 106
BOEHRINGER INGELHEIM/VETMEDICA 106
HESKA 106
MERCK 106
MERIAL 107
NOVARTIS 108
PFIZER 108
FOOD ANIMAL VACCINES 108
BAYER 108
BOEHRINGER INGELHEIM 108
MERCK & COMPANY 109
MERIAL 110
NOVARTIS 110
PFIZER 110
MARKET ANALYSIS AND CONCLUSIONS 111
MARKETS BY USE OR APPLICATION 111
TABLE 25 MARKET ANALYSIS FOR ANIMAL VACCINES BY USE,
THROUGH 2016 ($ MILLIONS) 111
FIGURE 9 MARKET ANALYSIS FOR ANIMAL VACCINES BY USE,
2008-2016 ($ MILLIONS) 112
VACCINE MARKET BY TYPE 112
TABLE 26 ESTIMATED REVENUES FOR ANIMAL VACCINES BY
TYPE, THROUGH 2016 ($ MILLIONS) 113
FIGURE 10 ESTIMATED REVENUES FOR ANIMAL VACCINES BY
TYPE, 2008-2016 ($ MILLIONS) 114
MARKETS BY GEOGRAPHICAL REGION 114
TABLE 27 DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES
BY WORLD REGION, 2011 (%/$ MILLIONS) 115
FIGURE 11 DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES
BY WORLD REGION, 2011 (%) 115
COMPETITIVE SUMMARY 116
TABLE 28 COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY
COMPETITOR REVENUE, 2011 (%/$ MILLIONS) 116
FIGURE 12 COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY
COMPETITOR REVENUE, 2011 ($ MILLIONS) 117
CHAPTER SIX: ANIMAL PHARMACEUTICAL PRODUCTS 118
OVERVIEW 118
PRODUCT DESCRIPTION 118
ALLERGY AND RESPIRATORY DRUGS 118
TARGET SPECIES AND PROVIDERS 119
TABLE 29 ALLERGY AND RESPIRATORY DRUGS BY TARGET
SPECIES AND PROVIDERS 119
ANTI-INFECTIVES AND ANTIFUNGALS 119
Bayer 120
Boehringer Ingelheim 120
ECO 120
Elanco 120
Esteve 121
Merck Animal Health 121
Novartis 122
Pfizer 122
Virbac 123
Target Species and Providers 123
TABLE 30 ANTI-INFECTIVES BY TARGET SPECIES AND
PROVIDERS 123
TABLE 30 (CONTINUED) 124
TABLE 30 (CONTINUED) 125
ANTI-INFLAMMATORIES AND ANALGESICS 125
Bayer 125
Boehringer Ingelheim 125
Esteve 125
Merck Animal Health 126
Novartis 126
Pfizer 126
Target Species and Providers 127
TABLE 31 ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET
SPECIES AND PROVIDERS 127
METABOLIC DRUGS 127
Target Species and Providers 128
TABLE 32 METABOLIC DRUGS BY TARGET SPECIES AND
PROVIDERS 128
PARASITICIDES 128
Bayer 129
ECO 129
Elanco 129
Merck Animal Health 130
Merial 131
Novartis 132
Novartis (Continued) 133
Pfizer 134
Virbac 134
Target Species and Providers 134
TABLE 33 PARASITICIDES BY TARGET SPECIES AND PROVIDERS 134
TABLE 33 (CONTINUED) 135
TABLE 33 (CONTINUED) 136
OTHER PHARMACEUTICALS 136
OPK Biotech 136
Elanco 136
Esteve 137
Merck Animal Health 137
Merial 137
Novartis 138
Virbac 138
Dental 138
Target Species and Providers 138
TABLE 34 OTHER PHARMACEUTICALS BY TARGET SPECIES AND
PROVIDERS 138
TABLE 34 (CONTINUED) 139
MARKET ANALYSIS AND CONCLUSIONS 139
MARKETS BY USE OR APPLICATION 139
Allergy and Respiratory Market 139
TABLE 35 MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY
PRODUCTS BY USE, THROUGH 2016 ($ MILLIONS) 140
FIGURE 13 MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY
PRODUCTS BY USE, 2008-2016 ($ MILLIONS) 140
Anti-Infective Market 141
TABLE 36 MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE,
THROUGH 2016 ($ MILLIONS) 141
FIGURE 14 MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE,
2008-2016 ($ MILLIONS) 142
Anti-Inflammatory Market 142
TABLE 37 MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND
ANALGESICS BY USE, THROUGH 2016 ($ MILLIONS) 143
FIGURE 15 MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND
ANALGESICS BY USE, 2008-2016 ($ MILLIONS) 143
Metabolic Drug Market 143
TABLE 38 MARKET ANALYSIS FOR METABOLIC DRUGS BY USE,
THROUGH 2016 ($ MILLIONS) 144
FIGURE 16 MARKET ANALYSIS FOR METABOLIC DRUGS BY USE,
2008-2016 ($ MILLIONS) 144
Parasiticide Market 145
TABLE 39 MARKET ANALYSIS FOR PARASITICIDES BY USE,
THROUGH 2016 ($ MILLIONS) 145
FIGURE 17 MARKET ANALYSIS FOR PARASITICIDES BY USE, 2008-
2016 ($ MILLIONS) 146
Other Pharmaceuticals 146
TABLE 40 MARKET ANALYSIS FOR OTHER PHARMACEUTICALS BY
USE, THROUGH 2016 ($ MILLIONS) 147
FIGURE 18 MARKET ANALYSIS FOR OTHER PHARMACEUTICALS
BY USE, 2008-2016 ($ MILLIONS) 147
TOTAL PHARMACEUTICALS 147
TABLE 41 MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL
PRODUCTS BY USE, THROUGH 2016 ($ MILLIONS) 148
FIGURE 19 MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL
PRODUCTS BY USE, 2008-2016 ($ MILLIONS) 148
SUMMARY—PHARMACEUTICAL MARKETS 149
TABLE 42 MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL
PRODUCTS BY TYPE, THROUGH 2016 ($ MILLIONS) 150
FIGURE 20 MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL
PRODUCTS BY TYPE, 2008-2016 ($ MILLIONS) 150
MARKETS BY GEOGRAPHICAL REGION 151
TABLE 43 DISTRIBUTION OF REVENUES FOR ANIMAL
PHARMACEUTICALS BY WORLD REGION, 2011 (%) 151
FIGURE 21 DISTRIBUTION OF REVENUES FOR ANIMAL
PHARMACEUTICALS BY WORLD REGION, 2011 (%) 152
COMPETITIVE SUMMARY 152
TABLE 44 COMPETITIVE SUMMARY FOR ANIMAL
PHARMACEUTICAL PRODUCTS BY COMPETITOR REVENUES,
2011 ($ MILLIONS) 153
FIGURE 22 COMPETITIVE SUMMARY FOR ANIMAL
PHARMACEUTICAL PRODUCTS BY COMPETITOR REVENUES,
2011 ($ MILLIONS) 153
CHAPTER SEVEN: ANIMAL FEED ADDITIVES 154
OVERVIEW 154
PRODUCT DESCRIPTION 155
AMINO ACIDS 155
ADISSEO 155
AJINOMOTO 155
EVONIK 156
NOVUS INTERNATIONAL 156
TARGET SPECIES AND PROVIDERS 156
TABLE 45 AMINO ACIDS BY TARGET SPECIES AND PROVIDERS 156
MEDICINAL ADDITIVES 157
ELANCO 157
MERIAL 157
NOVARTIS 157
PFIZER 158
TARGET SPECIES AND PROVIDERS 159
TABLE 46 MEDICINAL ADDITIVES BY TARGET SPECIES AND
PROVIDERS 159
NUTRITIONAL SUPPLEMENTS 160
ADISSEO 160
BASF 160
BOEHRINGER INGELHEIM 160
DSM NUTRITIONAL PRODUCTS 160
ESTEVE 161
HESKA 161
MOSAIC 161
VETERINARY PRODUCTS LABORATORIES 161
VIRBAC 161
TARGET SPECIES AND PROVIDERS 162
TABLE 47 NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
AND PROVIDERS 162
VITAMINS AND MINERALS 162
ADISSEO 163
BEAPHAR 163
CHURCH & DWIGHT CO 163
DSM NUTRITIONAL 163
MERCK ANIMAL HEALTH 163
PFIZER 164
TARGET SPECIES AND PROVIDERS 164
TABLE 48 VITAMINS AND MINERALS BY TARGET SPECIES AND
PROVIDERS 164
MARKET ANALYSIS AND CONCLUSION 165
MARKETS BY USE OR APPLICATION 165
Amino Acid Market 165
TABLE 49 MARKET ANALYSIS FOR AMINO ACIDS BY USE,
THROUGH 2016 ($ MILLIONS) 165
FIGURE 23 MARKET ANALYSIS FOR AMINO ACIDS BY USE, 2008-
2016 ($ MILLIONS) 166
Medicinal Feed Additive Market 166
TABLE 50 MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES
BY USE, THROUGH 2016 ($ MILLIONS) 167
FIGURE 24 MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES
BY USE, 2008-2016 ($ MILLIONS) 167
Nutritional Supplement Market 167
TABLE 51 MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS
BY USE, THROUGH 2016 ($ MILLIONS) 168
FIGURE 25 MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS
BY USE, 2008-2016 ($ MILLIONS) 169
Vitamin and Mineral Market 169
TABLE 52 MARKET ANALYSIS FOR VITAMINS AND MINERALS BY
USE, THROUGH 2016 ($ MILLIONS) 170
FIGURE 26 MARKET ANALYSIS FOR VITAMINS AND MINERALS BY
USE, 2008-2016 ($ MILLIONS) 170
Total Feed Additive Market 170
TABLE 53 MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY
USE, THROUGH 2016 ($ MILLIONS) 171
FIGURE 27 MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY
USE, 2008-2016 ($ MILLIONS) 171
FEED ADDITIVE MARKET BY TYPE 172
TABLE 54 MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE
PRODUCTS BY TYPE, THROUGH 2016 ($ MILLIONS) 173
FIGURE 28 MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE
PRODUCTS BY TYPE, 2008-2016 ($ MILLIONS) 173
MARKETS BY GEOGRAPHICAL REGION 174
TABLE 55 DISTRIBUTION OF REVENUES FOR ANIMAL FEED
ADDITIVES BY WORLD REGION, 2011 (%) 174
FIGURE 29 DISTRIBUTION OF REVENUES FOR ANIMAL FEED
ADDITIVES BY WORLD REGION, 2011 (%) 175
COMPETITIVE SUMMARY 175
TABLE 56 COMPETITIVE SUMMARY FOR ANIMAL FEED
ADDITIVES BY COMPETITOR REVENUES, 2011 (%/$ MILLIONS) 176
FIGURE 30 COMPETITIVE SUMMARY FOR ANIMAL FEED
ADDITIVES BY COMPETITOR REVENUES, 2011 ($ MILLIONS) 177
CHAPTER EIGHT: ANIMAL DIAGNOSTICS 178
OVERVIEW 178
PRODUCT DESCRIPTION 178
HESKA 178
IDEXX 179
IDEXX (Continued) 180
IDEXX (Continued) 181
MERCK ANIMAL HEALTH 182
SYNBIOTICS 182
TARGET SPECIES AND PROVIDERS 183
TABLE 57 DIAGNOSTICS BY TARGET SPECIES AND PROVIDERS 183
TABLE 57 (CONTINUED) 184
TABLE 57 (CONTINUED) 185
MARKET ANALYSIS AND CONCLUSION 186
MARKETS BY USE OR APPLICATION 186
TABLE 58 MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS
PRODUCTS BY USE, THROUGH 2016 ($ MILLIONS) 186
FIGURE 31 MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS
PRODUCTS BY USE, 2008-2016 ($ MILLIONS) 187
DIAGNOSTIC MARKET BY TYPE 187
TABLE 59 REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE,
THROUGH 2016 ($ MILLIONS) 188
FIGURE 32 REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE, 2008-
2016 ($ MILLIONS) 188
Diagnostic Rapid Testing 188
TABLE 60 REVENUES FOR RAPID DIAGNOSTICS BY TYPE
(VETERINARY APPLICATIONS), THROUGH 2016 ($ MILLIONS) 189
FIGURE 33 REVENUES FOR RAPID DIAGNOSTICS BY TYPE
(VETERINARY APPLICATIONS), 2008-2016 ($ MILLIONS) 190
Diagnostic Analyzers and Consumables 190
TABLE 61 REVENUES FOR DIAGNOSTIC ANALYZERS AND
CONSUMABLES BY TYPE (VETERINARY APPLICATIONS),
THROUGH 2016 ($ MILLIONS) 191
FIGURE 34 REVENUES FOR DIAGNOSTIC ANALYZERS AND
CONSUMABLES BY TYPE (VETERINARY APPLICATIONS), 2008-
2016 ($ MILLIONS) 191
Diagnostic Imaging Equipment 191
MARKETS BY GEOGRAPHICAL REGION 192
TABLE 62 DISTRIBUTION OF REVENUES FOR ANIMAL
DIAGNOSTICS BY WORLD REGION, 2011 (%/$ MILLIONS) 192
FIGURE 35 DISTRIBUTION OF REVENUES FOR ANIMAL
DIAGNOSTICS BY WORLD REGION, 2011 (%) 193
COMPETITIVE SUMMARY 193
TABLE 63 COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS
BY COMPETITOR REVENUES, 2011 ($ MILLIONS) 194
FIGURE 36 COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS
BY COMPETITOR REVENUES, 2011 ($ MILLIONS) 194
CHAPTER NINE: MARKET SUMMARY 195
TOTAL ANIMAL THERAPEUTICS AND DIAGNOSTIC MARKET
ANALYSIS 195
TABLE 64 TOTAL MARKET ANALYSIS FOR ANIMAL
THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT,
THROUGH 2016 ($ MILLIONS) 195
FIGURE 37 TOTAL MARKET ANALYSIS FOR ANIMAL
THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT,
2008-2016 ($ MILLIONS) 196
MARKETS BY USE OR APPLICATION 196
TABLE 65 TOTAL MARKET ANALYSIS FOR ANIMAL
THERAPEUTICS AND DIAGNOSTICS BY ANIMAL TYPE,
THROUGH 2016 ($ MILLIONS) 197
FIGURE 38 TOTAL MARKET ANALYSIS FOR ANIMAL
THERAPEUTICS AND DIAGNOSTICS BY ANIMAL TYPE, 2008-2016
($ MILLIONS) 198
MARKETS BY WORLD REGION 198
TABLE 66 DISTRIBUTION OF REVENUES FOR ANIMAL
THERPEUTICS AND DIAGNOSTICS BY WORLD REGION, 2011
(%/$ MILLIONS) 199
FIGURE 39 DISTRIBUTION OF REVENUES FOR ANIMAL
THERAPEUTICS AND DIAGNOSTICS BY WORLD REGION, 2011
(%) 200
INDUSTRY PARTICIPANTS BY TYPE 200
TABLE 67 MAJOR INDUSTRY PARTICIPANTS BY PRODUCT TYPE 201
TOTAL COMPETITIVE ANALYSIS 201
Total Competitive Analysis (Continued) 202
TABLE 68 TOTAL COMPETITIVE MARKET SHARE FOR ANIMAL
THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER
REVENUES, 2011 ($ MILLIONS) 203
FIGURE 40 TOTAL COMPETITIVE SUMMARY FOR ANIMAL
THERAPEUTICS AND DIAGNOSTICS BY COMPETITOR
REVENUES, 2011 ($ MILLIONS) 204
TABLE 69 COMPETITOR MARKET POSITION—ANIMAL
THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER
REVENUES, 2011 204
TABLE 69 (CONTINUED) 205
COMPANY ACQUISITIONS AND STRATEGIES 205
CHAPTER TEN: COMPANY PROFILES 206
ABAXIS INC 206
AUV VETERINARY COOPERATIVE 207
BASF ANIMAL NUTRITION (BASF SE) 208
BAYER ANIMAL HEALTH 208
BOEHRINGER INGELHEIM CORP 209
BOEHRINGER INGELHEIM GMBH 209
BOEHRINGER INGELHEIM VETMEDICA, INC 209
DSM NUTRITIONAL PRODUCTS LTD 210
ROYAL DSM N V 210
ELANCO ANIMAL HEALTH 210
EVONIK INDUSTRIES AG 211
HESKA CORP 212
IDEXX LABORATORIES INC 212
MERCK & CO INC 213
MOSAIC CO (THE) 214
NOVARTIS ANIMAL HEALTH INC 214
NOVARTIS AG 215
NOVUS INTERNATIONAL INC 215
PFIZER ANIMAL HEALTH 216
SANOFI 217
VIRBAC SA 218
APPENDICES 219
APPENDIX I: LEADING MANUFACTURES AND AFFILIATED
COMPANIES 219
ABAXIS INC 219
ACRUX LTD 219
ADISSEO FRANCE S A S 219
ADISSEO HONG KONG 219
AJINOMOTO CO LTD 220
AUV VETERINARY COOPERATIVE 220
BASF ANIMAL NUTRITION (BASF SE) 220
BAYER AG 220
BEAPHAR B V 220
BEN VENUE LABORATORIES INC 220
BOEHRINGER INGELHEIM CORP 221
BOEHRINGER INGELHEIM GMBH 221
BOEHRINGER INGELHEIM VETMEDICA INC 221
DSM NUTRITIONAL PRODUCTS LTD 221
ECO ANIMAL HEALTH 221
ELANCO ANIMAL HEALTH 221
ELI LILLY & CO 221
ESTEVE 222
ESTEVE USA INC 222
EUROVET 222
EVONIK INDUSTRIES AG 222
HESKA CORP 222
HUVEPHARMA AD 222
IDEXX LABORATORIES INC 223
LUITPOLD ANIMAL HEALTH 223
MERCK & CO INC 223
MERIAL ANIMAL HEALTH, LTD 223
MOSAIC CO (THE) 223
NOVARTIS AG 223
NOVARTIS ANIMAL HEALTH INC 224
NOVUS INTERNATIONAL INC 224
OPK BIOTECH LLC 224
PFIZER ANIMAL HEALTH 224
PHIBRO ANIMAL HEALTH CORPORATION 224
ROYAL DSM N V 224
SANOFI 225
SYNBIOTICS CORP 225
VIRBAC SA 225
APPENDIX II: RELEVANT ASSOCIATIONS AND ORGANIZATIONS 225
AMERICAN ASSOCIATION OF FELINE PRACTITIONERS 225
AMERICAN ASSOCIATION OF SWINE VETERINARIANS 225
AMERICAN HUMANE ASSOCIATION 225
AMERICAN PET PRODUCTS ASSOCIATION INC 225
AMERICAN SOCIETY FOR THE PREVENTION OF CRUELTY
TO ANIMALS 226
AMERICAN VETERINARY DISTRIBUTORS ASSOCIATION
(AVDA) 226
AMERICAN VETERINARY MEDICAL ASSOCIATION 226
CANADIAN VETERINARY MEDICAL ASSOCIATION 226
HUMANE SOCIETY OF THE UNITED STATES 226
NATIONAL ANIMAL CONTROL ASSOCIATION 226
PET FOOD INSTITUTE 227
SOCIETY OF ANIMAL WELFARE ADMINISTRATORS 227
UNITED STATES DEPARTMENT OF AGRICULTURE 227
UNITED STATES FOOD AND DRUG ADMINISTRATION 227
U S POULTRY AND EGG ASSOCIATION 227
